← Back to all publications

Intentional Fibonacci-Lucas-guided peptide design as a prospective experimental factor: A falsifiable, patient-centred framework for GLP-1, GIP and related therapeutics within the Geier equilibrium programme (A first approach)

Stefan A Geier, Caroline Geier, Stephanie Geier, Constantin Geier, Katharina Geier, Nora Blättermann-Goldstein, Michèle Geier-Noehl

Discovered via OpenAlex

Abstract

No abstract is available for this publication.

Read full article View raw RSS